Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 14505-14506 [E8-5398]

Download as PDF Federal Register / Vol. 73, No. 53 / Tuesday, March 18, 2008 / Notices mstockstill on PROD1PC66 with NOTICES development of specialized tools and processes. Moreover, this effort may result in the potential spread of contamination within the SFP water. The filters have degraded over time and any recovery attempts may result in the possible discharge of fuel pellets or fuel fragments into the SFP. Further, removal of the loose pellets and fuel fragments from the container would be difficult as a result of this material (fuel pellets) being entangled within the filter medium. Environmental Impacts of the Proposed Action NRC has completed its safety evaluation of the proposed action and concludes that the underlying purposes of 10 CFR 74.19(c) is to ensure that SNM is properly accounted for, appropriately secured and authorities are informed of any theft, diversion, or loss. Allowing the licensee to address the physical inventory of the loose fuel pellets within the pellet-can by the use of a video inspection of the interior without disturbing the contents will assure that the SNM in the pellet-can is accounted for. Limiting the movement of the pellet-can will assure that, in its degraded condition, it will not fail and potentially allow the fuel pellets to become lost in the SFP. Therefore, there is no undue risk to public health and safety. The details of the staff’s safety evaluation will be provided in the exemption that will be issued as part of the letter to the licensee approving the exemption to the regulation. The proposed action will not significantly increase the probability or consequences of accidents. No changes are being made in the types of effluents that may be released off site. Granting the proposed exemption request will not result in a significant increase in the amount of any effluent released off-site nor will it result in any significant increase in occupational or public radiation exposure. Therefore, there are no significant radiological environmental impacts associated with the proposed action. With regard to potential nonradiological impacts, the proposed action does not have a potential to cause effects on any historic properties. It does not affect non-radiological plant effluents and has no other environmental impact. Therefore, there are no significant non-radiological environmental impacts associated with the proposed action. Accordingly, the NRC concludes that there are no significant environmental impacts associated with the proposed action. VerDate Aug<31>2005 17:39 Mar 17, 2008 Jkt 214001 Environmental Impacts of the Alternatives to the Proposed Action As an alternative to the proposed action, the staff considered denial of the proposed action (i.e., the ‘‘no-action’’ alternative). Denial of the application would result in no change in current environmental impacts. The environmental impacts of the proposed action and the alternative action are similar. Alternative Use of Resources The action does not involve the use of any different resources than those previously considered in the ‘‘Generic Environmental Impact Statement for License Renewal of Nuclear Plants, Supplement 8 (Regarding McGuire Nuclear Station Units 1 and 2),’’ NUREG–1437, dated December 2002. Agencies and Persons Consulted In accordance with its stated policy, on March 10, 2007, the staff consulted with the North Carolina State official, Dale Dusenbury of the North Carolina Department of Environment and Natural Resources, regarding the environmental impact of the proposed action. The State official had no comments. Finding of No Significant Impact On the basis of the environmental assessment, the NRC concludes that the proposed action will not have a significant effect on the quality of the human environment. Accordingly, the NRC has determined not to prepare an environmental impact statement for the proposed action. For further details with respect to the proposed action, see the licensee’s letter dated December 3, 2007. Documents may be examined, and/or copied for a fee, at the NRC’s Public Document Room (PDR), located at One White Flint North, Public File Area O1 F21, 11555 Rockville Pike (first floor), Rockville, Maryland. Publicly available records will be accessible electronically from the Agencywide Documents Access and Management System (ADAMS) Public Electronic Reading Room on the Internet at the NRC Web site, https:// www.nrc.gov/reading-rm/adams.html. Persons who do not have access to ADAMS or who encounter problems in accessing the documents located in ADAMS should contact the NRC PDR Reference staff by telephone at 1–800– 397–4209 or 301–415–4737, or send an e-mail to pdr@nrc.gov. Dated at Rockville, Maryland, this 12th day of March 2008. PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 14505 For the Nuclear Regulatory Commission. John Stang, Senior Project Manager, Plant Licensing Branch II–1, Division of Operating Reactor Licensing, Office of Nuclear Reactor Regulation. [FR Doc. E8–5383 Filed 3–17–08; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice U.S. Nuclear Regulatory Commission. ACTION: Notice of meeting. AGENCY: SUMMARY: NRC will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) April 28–29, 2008. A sample of agenda items to be discussed during the public session includes: (1) ACMUI comments on the National Academies of Sciences report (https://www.nap.edu/ catalog.php?record_id=11976); (2) ACMUI subcommittee recommendations on regulating the Leksell Gamma-Knife PerfexionTM; (3) potential revisions to the Abnormal Occurrence criteria; (4) subcommittee report on medical events and analysis of causes; (5) emerging technology; (6) yttrium 90 microsphere guidance; (7) status of active petitions for rulemaking; (8) NARM transition plan update; and (9) status of specialty board applications for NRC recognition. A copy of the agenda will be available at https:// www.nrc.gov/reading-rm/doccollections/acmui/agenda or by emailing Ms. Ashley M. Tull at the contact information below. Purpose: Discuss issues related to 10 CFR Part 35 Medical Use of Byproduct Material. Date and Time for Closed Sessions: April 28, 2008 from 3:30 p.m. to 5:30 p.m. This session will be closed so that NRC staff and ACMUI can prepare for the Commission meeting. Date and Time for Open Sessions: April 28, 2008, from 8 a.m. to 3:30 p.m. and April 29, 2008, from 8 a.m. to 3 p.m. Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two White Flint North Building, Room T2– B3, 11545 Rockville Pike, Rockville, Maryland 20852. Public Participation: Any member of the public who wishes to participate in the meeting should contact Ms. Tull using the information below. Contact Information: Ashley M. Tull, e-mail: amt1@nrc.gov, telephone: (301) 415–5294 or (918) 488–0552. E:\FR\FM\18MRN1.SGM 18MRN1 14506 Federal Register / Vol. 73, No. 53 / Tuesday, March 18, 2008 / Notices Conduct of the Meeting Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Tull at the contact information listed above. All submittals must be received by April 21, 2008, and must pertain to the topic on the agenda for the meeting. 2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the Chairman. 3. The transcript will be available for inspection on ACMUI’s Web site (https://www.nrc.gov/reading-rm/doccollections/acmui/tr/) on or about July 28, 2008. Minutes of the meeting will be available on or about June 11, 2008. 4. Persons who require special services, such as those for the hearing impaired, should notify Ms. Tull of their planned attendance. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission’s regulations in Title 10, U.S. Code of Federal Regulations, Part 7. c. Pa’ina Hawaii, LLC (Materials License Application) Atomic Safety and Licensing Board’s Decision on Environmental Contentions (Dec. 21, 2007) (Tentative). d. Pacific Gas and Electric Co. (Diablo Canyon ISFSI), Docket No.72–26-ISFSI, San Luis Obispo Mothers for Peace’s Response to NRC Staff’s Vaughn Index, Request for Leave to Conduct Discovery Against the NRC Staff, Request for Access to Unredacted Reference Documents, and Request for Procedures to Protect Submission of Sensitive Information (Tentative). This meeting will be Webcast live at the Web address—https://www.nrc.gov. 1 p.m. Briefing on State of NRC Technical Programs (Public Meeting). (Contact: Tamara Bloomer, 301 415– 1725). This meeting will be Webcast live at the Web address—https://www.nrc.gov. Tuesday, March 18, 2008 9:30 a.m. Briefing by Independent External Panel to Identify Vulnerabilities in the U.S. NRC’s Materials Licensing Program (Public Meeting). (Contact: Aaron T. McCraw, 301–415–1277). This meeting will be Webcast live at the Web address—https://www.nrc.gov. Week of March 24, 2008—Tentative Thursday, March 27, 2008 Dated: March 12, 2008. Andrew L. Bates, Advisory Committee Management Officer. [FR Doc. E8–5398 Filed 3–17–08; 8:45 am] 9:30 a.m. Discussion of Management Issues (Closed—Ex. 2). Week of March 31, 2008—Tentative BILLING CODE 7590–01–P There are no meetings scheduled for the Week of March 31, 2008. NUCLEAR REGULATORY COMMISSION Week of April 7, 2008—Tentative Monday, April 7, 2008 Sunshine Federal Register Notice AGENCY HOLDING THE MEETINGS: Nuclear Regulatory Commission. DATE: Weeks of March 17, 24, 31, April 7, 14, 21, 2008. PLACE: Commissioners’ Conference Room, 11555 Rockville Pike, Rockville, Maryland. STATUS: Public and Closed. MATTERS TO BE CONSIDERED: Week of March 17, 2008 mstockstill on PROD1PC66 with NOTICES Monday, March 17, 2008 12:55 p.m. Affirmation Session (Public Meeting) (Tentative) a. Final Rule—10 CFR Part 73 ‘‘Safeguards Information Protection Requirements’’ (Rin 3150 AH57) (Tentative). b. Pa’ina Hawaii, LLC (Materials License Application) (Tentative). VerDate Aug<31>2005 17:39 Mar 17, 2008 Jkt 214001 9:30 a.m. Briefing on Digital Instrumentation and Control (Public Meeting). (Contact: Steven Arndt, 301 415–6502). This meeting will be Webcast live at the Web address—https://www.nrc.gov. Tuesday, April 8, 2008 10 a.m. Joint Meeting of the Federal Energy Regulatory Commission (FERC) and the Nuclear Regulatory Commission (NRC) (Public Meeting). To be Held at FERC Headquarters, 888 First Street NE., Washington, DC. (Contact: Michelle Schroll, 301 415– 1662). This meeting will be Webcast live at the Web address—https://www.ferc.gov. Wednesday, April 9, 2008 1 p.m. Discussion of Management Issues (Closed-Ex. 2). PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 Week of April 14, 2008 —Tentative There are no meetings scheduled for the Week of April 14, 2008. Week of April 21, 2008—Tentative There are no meetings scheduled for the Week of April 21, 2008. * * * * * *The schedule for Commission meetings is subject to change on short notice. To verify the status of meetings, call (recording)—(301) 415–1292. Contact person for more information: Michelle Schroll, (301) 415–1662. * * * * * The NRC Commission Meeting Schedule can be found on the Internet at: https://www.nrc.gov/about-nrc/policymaking/schedule.html. * * * * * The NRC provides reasonable accommodation to individuals with disabilities where appropriate. If you need a reasonable accommodation to participate in these public meetings, or need this meeting notice or the transcript or other information from the public meetings in another format (e.g. braille, large print), please notify the NRC’s Disability Program Coordinator, Rohn Brown, at 301–492–2279, TDD: 301–415–2100, or by e-mail at REB3@nrc.gov. Determinations on requests for reasonable accommodation will be made on a case-by-case basis. * * * * * This notice is distributed by mail to several hundred subscribers; if you no longer wish to receive it, or would like to be added to the distribution, please contact the Office of the Secretary, Washington, DC 20555 (301–415–1969). In addition, distribution of this meeting notice over the Internet system is available. If you are interested in receiving this Commission meeting schedule electronically, please send an electronic message to dkw@nrc.gov. Dated: March 13, 2008. R. Michelle Schroll, Office of the Secretary. [FR Doc. 08–1045 Filed 3–14–08; 10:32 am] BILLING CODE 7590–01–P SECURITIES AND EXCHANGE COMMISSION Proposed Collection; Comment Request Upon written request, copies available from: Securities and Exchange Commission, Office of Investor Education and Advocacy, Washington, DC 20549–0213. Extension: Regulation S–X, SEC File No. 270, E:\FR\FM\18MRN1.SGM 18MRN1

Agencies

[Federal Register Volume 73, Number 53 (Tuesday, March 18, 2008)]
[Notices]
[Pages 14505-14506]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-5398]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: NRC will convene a meeting of the Advisory Committee on the 
Medical Uses of Isotopes (ACMUI) April 28-29, 2008. A sample of agenda 
items to be discussed during the public session includes: (1) ACMUI 
comments on the National Academies of Sciences report (https://
www.nap.edu/catalog.php?record_id=11976); (2) ACMUI subcommittee 
recommendations on regulating the Leksell Gamma-Knife[reg] 
Perfexion\TM\; (3) potential revisions to the Abnormal Occurrence 
criteria; (4) subcommittee report on medical events and analysis of 
causes; (5) emerging technology; (6) yttrium 90 microsphere guidance; 
(7) status of active petitions for rulemaking; (8) NARM transition plan 
update; and (9) status of specialty board applications for NRC 
recognition. A copy of the agenda will be available at https://
www.nrc.gov/reading-rm/doc-collections/acmui/agenda or by e-mailing Ms. 
Ashley M. Tull at the contact information below.
    Purpose: Discuss issues related to 10 CFR Part 35 Medical Use of 
Byproduct Material.
    Date and Time for Closed Sessions: April 28, 2008 from 3:30 p.m. to 
5:30 p.m. This session will be closed so that NRC staff and ACMUI can 
prepare for the Commission meeting.
    Date and Time for Open Sessions: April 28, 2008, from 8 a.m. to 
3:30 p.m. and April 29, 2008, from 8 a.m. to 3 p.m.
    Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two 
White Flint North Building, Room T2-B3, 11545 Rockville Pike, 
Rockville, Maryland 20852.
    Public Participation: Any member of the public who wishes to 
participate in the meeting should contact Ms. Tull using the 
information below.
    Contact Information: Ashley M. Tull, e-mail: amt1@nrc.gov, 
telephone: (301) 415-5294 or (918) 488-0552.

[[Page 14506]]

Conduct of the Meeting

    Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Tull at the contact information listed above. 
All submittals must be received by April 21, 2008, and must pertain to 
the topic on the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The transcript will be available for inspection on ACMUI's Web 
site (https://www.nrc.gov/reading-rm/doc-collections/acmui/tr/) on or 
about July 28, 2008. Minutes of the meeting will be available on or 
about June 11, 2008.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Tull of their planned attendance.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10, U.S. Code of Federal Regulations, Part 7.

    Dated: March 12, 2008.
Andrew L. Bates,
Advisory Committee Management Officer.
 [FR Doc. E8-5398 Filed 3-17-08; 8:45 am]
BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.